BioReference Health

BioReference Health Empowering confident healthcare decisions through trusted laboratory service & diagnostic excellence. BioReference® Health LLC, an OPKO Health, Inc.

Company (NASDAQ: OPK), empowers confident healthcare decisions by prioritizing service, creating innovative solutions, and offering scientific expertise in oncology, urology, and women’s health. Headquartered in Elmwood Park, New Jersey, BioReference operates 10 laboratory facilities around the country, is in-network with the largest health plans in the United States and processes more than 12 mil

lion tests, annually. BioReference provides credible and tailored solutions for a variety of customers and patients, including medical practices small and large, hospitals and health systems, correctional institutions, government agencies, educational systems, and sport leagues. In addition to an extensive test menu with 99 percent of tests performed in-house, BioReference’s differentiated offerings include large-scale health screening programs, on-demand mobile phlebotomy, and transformative business solutions that optimize laboratory management. For more information visit https://www.bioreference.com/

We are thrilled that Ellen Beausang, Chief Commercial Officer at BioReference/GenPath, will be one of the featured speak...
10/31/2024

We are thrilled that Ellen Beausang, Chief Commercial Officer at BioReference/GenPath, will be one of the featured speakers at the pre-conference workshop at Pathology Visions '24 on November 3, 2024. Ellen will speak about how we successfully integrated artificial intelligence into our remote pathology offering, Stormpath, and how this helps our clients report professional interpretations of esoteric testing more quickly and accurately.

https://www.gestaltdiagnostics.com/

Photo credit: Gestalt Diagnostics

BioReference® today announced we will implement SOPHiA GENETICS technology and add MSK-ACCESS® liquid biopsy to our test...
11/07/2023

BioReference® today announced we will implement SOPHiA GENETICS technology and add MSK-ACCESS® liquid biopsy to our test suite. With the implementation of SOPHiA GENETICS, BioReference will be the first laboratory globally to adopt MSK-ACCESS® powered with SOPHiA DDM™. Click to read the full release ➡️
https://bit.ly/3SyP7qP

09/14/2023

Today we kicked-off day one of the American Pathology Foundation National Meeting to promote the practice management and leadership of pathology through training and education. If you are in attendance, please join various exciting sessions this week hosted by BioReference colleagues Tamera Paczos, MD; Jane Pine Wood, JD; and Robin Miller Zweifel, MT (ASCP). View the conference agenda here ➡️

The American Pathology Foundation (APF) is a non-profit professional society devoted to the business and management of pathology. Founded in 1959 by pathologist leaders and laboratory industry executives, APF strives to provide high quality educational programs and practice management resources.

Routine tests play a critical role in healthcare, informing 70% of medical decisions (according to the CDC). Without con...
06/14/2023

Routine tests play a critical role in healthcare, informing 70% of medical decisions (according to the CDC). Without congressional action, about 800 tests will face payment cuts, threatening access to care. Take action with the American Clinical Laboratory Association and tell Congress to pass , by signing the petition here: https://bit.ly/3Sg5Xr5

Address

481 Edward H Ross Drive
Elmwood Park, NJ
07407

Telephone

+18882790967

Website

Alerts

Be the first to know and let us send you an email when BioReference Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to BioReference Health:

Shortcuts

Share

Category